Piperidine Derivatives as Radiotracers for Serotonin Transporters
哌啶衍生物作为血清素转运蛋白的放射性示踪剂
基本信息
- 批准号:6681288
- 负责人:
- 金额:$ 11.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-08-14 至 2005-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant):
The goal of this research project is to define the structure and radioactive label for ligands that will permit quantitative measurement of serotonin transporter (5-HTT) sites in living brain by external imaging with positron (PET) or single photon (SPECT) emission tomography. The serotonin transporter is known to play a role in several physiological and pathophysiological processes, especially in depression, anxiety, seasonal affective disorder, bulimia, and psychosis, as demonstrated by post-mortem and preliminary imaging studies. A radiotracer that bound specifically to 5-HTT would be of great utility in diagnosis, monitoring treatment, and research of such disorders. However, there is not yet a suitable tracer that allows quantitation in areas of the brain with low densities of 5-HTT, such as the cortex. Based on preliminary in vitro binding results using a classical structure-activity relationship approach, we found that certain 4'-biphenyl analogs of phenyltropanes showed nanomolar affinity to 5-HTT and >50-fold selectivity with respect to other monoamine transporters. In this application we propose to test the following hypotheses: 1) derivatives with pi-donor substituents on the 4'-position of 4-phenyl piperidine will favor binding to 5-HTT relative to dopamine transporter (DAT) and norepinephrine transporter (NET); and 2) elimination of the C6-C7 bridge of the tropane (to yield piperidine analogs) will reduce the lipophilicity of our compounds and have lower nonspecific binding than the corresponding tropane or nor-tropane compound.
描述(由申请人提供):
这项研究项目的目标是确定配体的结构和放射性标记,以便通过正电子(PET)或单光子(SPECT)发射断层扫描的外部成像来定量测量活体大脑中的5-HTT位点。已知5-羟色胺转运体在几个生理和病理生理过程中发挥作用,特别是在抑郁、焦虑、季节性情感障碍、暴食症和精神病中,尸检和初步成像研究表明。特异性结合5-HTT的放射性示踪剂将在此类疾病的诊断、监测、治疗和研究中发挥重要作用。然而,目前还没有一种合适的示踪剂可以在大脑中5-HTT浓度较低的区域进行定量,比如大脑皮层。基于经典构效关系方法的初步体外结合结果,我们发现某些苯基托烷的4‘-联苯类似物对5-HTT和~gt;的纳摩尔亲和力是其他单胺转运体的50倍。在这一应用中,我们建议检验以下假设:1)4-苯基哌啶4‘-位带有pi-给体取代基的衍生物将有利于与5-HTT相对于多巴胺转运体(DAT)和去甲肾上腺素转运体(NET)的结合;以及2)消除托烷的C6-C7桥(以生成哌啶类似物)将降低化合物的亲脂性,并且与相应的托烷或去甲托烷化合物相比,非特异性结合更低。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GILLES D TAMAGNAN其他文献
GILLES D TAMAGNAN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GILLES D TAMAGNAN', 18)}}的其他基金
A Program for Innovative PET Radioligand Development and Application - a translational toolbox for treatments for Mental Health
创新 PET 放射性配体开发和应用计划 - 心理健康治疗的转化工具箱
- 批准号:
8957207 - 财政年份:2015
- 资助金额:
$ 11.74万 - 项目类别:
In vivo evaluation of a new ligand with picomolar affinity for the serotonin tran
对血清素反式具有皮摩尔亲和力的新配体的体内评价
- 批准号:
7547066 - 财政年份:2008
- 资助金额:
$ 11.74万 - 项目类别:
In vivo evaluation of a new ligand with picomolar affinity for the serotonin tran
对血清素反式具有皮摩尔亲和力的新配体的体内评价
- 批准号:
7399724 - 财政年份:2008
- 资助金额:
$ 11.74万 - 项目类别:
Indole Glyoxylamides Peripheral Benzodiazepine Receptor
吲哚乙醛酰胺外周苯二氮卓受体
- 批准号:
7110892 - 财政年份:2006
- 资助金额:
$ 11.74万 - 项目类别:
Indole Glyoxylamides Peripheral Benzodiazepine Receptor Radiotracers
吲哚乙醛酰胺外周苯二氮卓受体放射性示踪剂
- 批准号:
7244240 - 财政年份:2006
- 资助金额:
$ 11.74万 - 项目类别:
AZABICYCLONONANE SEROTONIN TRANSPORTER RADIOTRACERS
氮杂环壬烷血清素转运体放射性示踪剂
- 批准号:
6950024 - 财政年份:2004
- 资助金额:
$ 11.74万 - 项目类别:
AZA BICYCLO NONANE SEROTONIN TRANSPORTER RADIOTRACERS
AZA 双环壬烷血清素转运体放射性示踪剂
- 批准号:
6790750 - 财政年份:2004
- 资助金额:
$ 11.74万 - 项目类别:
Novel VMAT 2 Radioligand for Imaging Parkinson's
用于帕金森病成像的新型 VMAT 2 放射性配体
- 批准号:
6691941 - 财政年份:2003
- 资助金额:
$ 11.74万 - 项目类别:
相似海外基金
Defining the role of dopamine transporter in the hierarchical organization of colorectal tumors
定义多巴胺转运蛋白在结直肠肿瘤分层组织中的作用
- 批准号:
489026 - 财政年份:2023
- 资助金额:
$ 11.74万 - 项目类别:
Operating Grants
Investigation of dopamine transporter dysfunction linked to DAT/SLC6A3 mutations in CRISPR-Cas engineered C. elegans and patient derived iPSCs
研究 CRISPR-Cas 改造的线虫和患者来源的 iPSC 中与 DAT/SLC6A3 突变相关的多巴胺转运蛋白功能障碍
- 批准号:
2740761 - 财政年份:2022
- 资助金额:
$ 11.74万 - 项目类别:
Studentship
Development of a New Quantitative Analysis Method for Short-Time Collection in Brain Dopamine Transporter Imaging
脑多巴胺转运蛋白成像中短时采集的新定量分析方法的开发
- 批准号:
22K07632 - 财政年份:2022
- 资助金额:
$ 11.74万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Investigation of dopamine transporter dysfunction linked to DAT/SLC6A3 mutations in CRISPR-Cas engineered C. elegans and patient derived iPCSs
研究 CRISPR-Cas 改造的线虫和患者来源的 iPCS 中与 DAT/SLC6A3 突变相关的多巴胺转运蛋白功能障碍
- 批准号:
NC/W001659/1 - 财政年份:2022
- 资助金额:
$ 11.74万 - 项目类别:
Training Grant
In vivo synaptic and dopamine transporter imaging in Parkinson's disease
帕金森病的体内突触和多巴胺转运蛋白成像
- 批准号:
10521681 - 财政年份:2022
- 资助金额:
$ 11.74万 - 项目类别:
In vivo synaptic and dopamine transporter imaging in Parkinson's disease
帕金森病的体内突触和多巴胺转运蛋白成像
- 批准号:
10671684 - 财政年份:2022
- 资助金额:
$ 11.74万 - 项目类别:
The Role of the Dopamine Transporter in Psychostimulant Abuse
多巴胺转运蛋白在精神兴奋剂滥用中的作用
- 批准号:
10402705 - 财政年份:2021
- 资助金额:
$ 11.74万 - 项目类别:
Dopamine transporter regulation of short-term plasticity in dopamine release
多巴胺转运蛋白对多巴胺释放短期可塑性的调节
- 批准号:
2607157 - 财政年份:2021
- 资助金额:
$ 11.74万 - 项目类别:
Studentship
A first-in-class orally bioavailable small molecule dual inhibitor targeting NLRP3 and the dopamine transporter to treat AD
首创的口服生物可利用小分子双重抑制剂,靶向 NLRP3 和多巴胺转运蛋白,用于治疗 AD
- 批准号:
10325722 - 财政年份:2021
- 资助金额:
$ 11.74万 - 项目类别:
Dopamine Transporter: Tools for in vivo molecular replacement
多巴胺转运蛋白:体内分子替代的工具
- 批准号:
9975977 - 财政年份:2020
- 资助金额:
$ 11.74万 - 项目类别: